Hhlr Advisors, Ltd. Leap Therapeutics, Inc. Transaction History

Hhlr Advisors, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$1.35 - $4.01 $4.83 Million - $14.3 Million	-3,575,745 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.82 - $3.01 $255,700 - $422,889	-140,495 Reduced 3.78%	3,575,745 $6.79 Million
Q3 2020 Nov 16, 2020	BUY	$1.68 - $2.17 $188,496 - $243,474	112,200 Added 3.11%	3,716,240 $7.36 Million
Q2 2020 Aug 14, 2020	BUY	$1.39 - $2.84 $5.01 Million - $10.2 Million	3,604,040 New	3,604,040 $7.53 Million

265K

Ticker LPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,021,400
Market Cap $288M
Description
Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.